Multibagger stock below Rs 250: Don't miss action in this stock that has announced rights issue!
The stock has returned 71.50 per cent year to date and in just one year, it has generated multibagger gains of 224.16 per cent.
One of the Top Gainers on BSE on Friday, shares of Shukra Pharmaceuticals Ltd soared 5 per cent upper circuit to Rs 226.90 per share. The stock also traded at a new 52-week high of Rs 226.90.
The company recently approved rights issue of 93,94,050 equity shares of face value of Rs 10 each (equity shares) to eligible equity shareholders aggregating up to Rs 1878.81 lakh. The company verified the record date for rights issue as Thursday, February 02, 2023.
Shukra Pharmaceuticals Ltd., incorporated in the year 1993, is a Small-Cap company (having a market cap of Rs 35.53 crore). It is engaged in the manufacturing and trading of pharmaceutical products and laboratory testing.
The company reported positive results in both quarterly and annual financial statements. In Q2FY23, net sales rose 24.83 per cent and net profit skyrocketed 300 per cent compared to Q2FY22. In FY22, the company did net sales of Rs 20.48 crore and net profit skyrocketed 295 per cent. The stock has a 1-year CAGR of 216 per cent.
The stock had successive upward circuits in recent trading sessions. The stock has returned 71.50 per cent year to date and in just one year, it has generated multibagger gains of 224.16 per cent. Investors should keep an eye on this multibagger stock.